Truvestments Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.43K | Hold |
258
| – | – | ﹤0.01% | 819 |
|
2025
Q1 | $1.4K | Hold |
258
| – | – | ﹤0.01% | 907 |
|
2024
Q4 | $1.92K | Hold |
258
| – | – | ﹤0.01% | 846 |
|
2024
Q3 | $2.06K | Buy |
+258
| New | +$2.06K | ﹤0.01% | 794 |
|
2024
Q2 | – | Sell |
-258
| Closed | -$5.33K | – | 389 |
|
2024
Q1 | $5.33K | Hold |
258
| – | – | ﹤0.01% | 548 |
|
2023
Q4 | $5.96K | Hold |
258
| – | – | ﹤0.01% | 575 |
|
2023
Q3 | $2.06K | Hold |
258
| – | – | ﹤0.01% | 590 |
|
2023
Q2 | $2.25K | Hold |
258
| – | – | ﹤0.01% | 594 |
|
2023
Q1 | $759 | Sell |
258
-193
| -43% | -$568 | ﹤0.01% | 618 |
|
2022
Q4 | $1.58K | Hold |
451
| – | – | ﹤0.01% | 770 |
|
2022
Q3 | $4K | Hold |
451
| – | – | ﹤0.01% | 485 |
|
2022
Q2 | $4K | Buy |
+451
| New | +$4K | ﹤0.01% | 494 |
|
2022
Q1 | – | Sell |
-258
| Closed | -$3K | – | 298 |
|
2021
Q4 | $3K | Hold |
258
| – | – | ﹤0.01% | 526 |
|
2021
Q3 | $3K | Hold |
258
| – | – | ﹤0.01% | 504 |
|
2021
Q2 | $2K | Hold |
258
| – | – | ﹤0.01% | 547 |
|
2021
Q1 | $3K | Buy |
+258
| New | +$3K | ﹤0.01% | 570 |
|